SCHEMBL18530569

SCHEMBL18530569

Nc1ccc(C=CC(=O)NCc2ccc(-c3ccc4cc(C(=O)N5CCC(F)(F)CC5)ccc4c3Cl)o2)cn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAK4 O96013 2/20 0.59
▸ NAMPT P43490 1/20 0.59
▸ PAK1 Q13153 1/20 0.59
▸ GPR183 P32249 4/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ HTR1A P08908 9/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ HDAC3 O15379 2/20 0.31
▸ HDAC4 P56524 2/20 0.31
▸ HDAC1 Q13547 2/20 0.31
▸ HDAC7 Q8WUI4 2/20 0.31
▸ HDAC2 Q92769 2/20 0.31
▸ HDAC10 Q969S8 2/20 0.31
▸ HDAC11 Q96DB2 2/20 0.31
▸ HDAC8 Q9BY41 2/20 0.31
▸ HDAC6 Q9UBN7 2/20 0.31
▸ HDAC9 Q9UKV0 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18530567 1.00 PAK4 (0.59) PAK4NAMPTPAK1GPR183LRRK2
SCHEMBL18542110 0.90 PAK4 (0.59) PAK4NAMPTPAK1GPR183LRRK2
SCHEMBL18542053 0.90 PAK4 (0.59) PAK4NAMPTPAK1GPR183LRRK2
SCHEMBL18530616 0.85 PAK4 (0.67) PAK4NAMPTPAK1GPR183HTR1A
SCHEMBL18530617 0.85 PAK4 (0.67) PAK4NAMPTPAK1GPR183HTR1A
SCHEMBL18530588 0.82 PAK4 (0.76) PAK4NAMPTPAK1GPR183KCNH2
SCHEMBL18530590 0.82 PAK4 (0.76) PAK4NAMPTPAK1GPR183KCNH2
SCHEMBL18530611 0.82 PAK4 (0.62) PAK4NAMPTPAK1HPGDGAA
SCHEMBL18530610 0.82 PAK4 (0.62) PAK4NAMPTPAK1HPGDGAA
SCHEMBL18530545 0.82 HTR1A (0.35) PAK4NAMPTPAK1LRRK2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3337796-A1 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS Karyopharm Therapeutics, Inc. (US) 2018-06-27 — — EP disclosed
WO-2017031213-A1 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS Karyopharm Therapeutics Inc. (US) 2017-02-23 — — WO disclosed
Send feedback